Skip to search formSkip to main contentSkip to account menu

Ethylphenylhydantoin

Known as: nirvanol, (+-)-3-Ethyl-5-phenylhydantoin, 5-phenyl-5-ethylhydantoin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Highly potent and selective CYP2C19 inhibitors are not currently available. In the present study, N-3-benzyl derivatives of… 
Highly Cited
2002
Highly Cited
2002
Cytochrome P450 2B6 is a genetically polymorphic enzyme that is important in the metabolism of a number of clinically used drugs… 
Highly Cited
1998
Highly Cited
1998
We tested the ability of human liver microsomes (HLMs) and recombinant human cytochrome P450 (CYP or P450) isoforms to catalyze… 
Highly Cited
1996
Highly Cited
1996
In vitro methods were used to identify the cytochrome P450 (CYP) enzyme(s) involved in S-mephenytoin N-demethylation. S… 
Highly Cited
1988
Highly Cited
1988
Male F344/NCr rats, 6 wk old, were fed 500 ppm of phenobarbital (PB) or equimolar doses of either 5-ethyl-5-phenylhydantoin (EPH… 
Highly Cited
1984
Highly Cited
1984
The frequency of genetically deficient hydroxylation of mephenytoin (M‐defect) was studied in 83 healthy Caucasians living in… 
1982
1982
A water-soluble metabolite, isolated from the urine of dogs given (S)-5-ethyl-5-phenylhydantoin [(S)-EPH], has been identified as… 
1979
1979
Effective prescribing of anticonvulsants requires foreknowledge of baseline pharmacokinetic data. Little such information is… 
1975
1975
We describe a modification of the MacGee method [Anal. Chem. 42, 421 (1970)] for rapid determination of phenytoin…